Inaddition, SOX2 can cooperate with another transcription factor, N-MYC, for CSCregulation and promotion of this aggressive prostate cancer subtype associated withTP53 and RB loss (Dardenne et al. 2016, Verma et al. 2023). This evidence concerns the gene SOX2 and prostate carcinoma.